Lincoln Pharmaceuticals Ltd (LINCOLN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 294056, "name": "Lincoln Pharma.", "stock_name": "Lincoln Pharma.", "full_name": "Lincoln Pharmaceuticals Ltd", "name_url": "stocks-analysis/lincoln-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "611.05", "chg": -20.2, "chgp": "-3.2%", "dir": -1, "prev_price": "631.25", "mcapval": "1,232.00 Cr", "mcap": "Micro Cap", "scripcode": 531633, "symbol": "LINCOLN", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE405C01035", "curr_date": "Jun 18, 03:30 PM", "curr_time": "19:55 PM", "last_traded_at": "Jun 18, 03:30 PM IST", "bse_nse_vol": "1.44 lacs", "exc_status": "Active", "traded_date": "Jun 18, 2026", "traded_date_str": "2026 06 18", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lincoln-pharma-294056-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4058041", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LincolnPharmace_technicaldot_4058041.png", "date": "2026-06-17 08:01:25", "description": "Lincoln Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from bullish to mildly bullish territory. Despite a slight dip in daily price, the stock’s longer-term technicals and fundamental returns continue to present a complex but cautiously optimistic outlook for investors in the Pharmaceuticals & Biotechnology sector." }, { "title": "Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-technical-momentum-shifts-signal-bullish-outlook-4054875", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LincolnPharmace_technicaldot_4054875.png", "date": "2026-06-16 08:01:30", "description": "Lincoln Pharmaceuticals Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by robust price action, positive signals from key technical indicators, and impressive returns that outpace the broader market benchmarks, signalling renewed investor interest in this micro-cap pharmaceutical player." }, { "title": "Lincoln Pharmaceuticals Declines 1.08%: Valuation Shift and Technical Momentum Define Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-declines-108-valuation-shift-and-technical-momentum-define-week-4053044", "imagepath": "", "date": "2026-06-14 13:02:14", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>1 Jun:</strong> Technical momentum shifts amid market volatility</p>\n <p><strong>2 Jun:</strong> Valuation upgrade to attractive signals renewed price appeal</p>\n <p><strong>4 Jun:</strong> Strong rebound with 5.05% gain</p>\n <p><strong>5 Jun:</strong> Week closes at Rs.625.05 (-1.08%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.631.90</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.625.05</div><div class=\"stat-change neg..." }, { "title": "Lincoln Pharmaceuticals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-is-rated-hold-4051058", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LincolnPharmace_mojoScore_4051058.png", "date": "2026-06-13 10:10:05", "description": "Lincoln Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 16 March 2026. While this rating change occurred in March, the analysis and financial metrics presented here reflect the stock's current position as of 13 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4045774", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LincolnPharmace_technicaldot_4045774.png", "date": "2026-06-11 08:01:19", "description": "Lincoln Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish trend as of mid-2026. While key indicators such as the MACD and Bollinger Bands maintain positive signals on weekly and monthly timeframes, divergences in RSI and KST readings suggest a complex outlook for investors navigating this micro-cap pharmaceutical stock." }, { "title": "Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-technical-momentum-shifts-signal-bullish-outlook-4043202", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LincolnPharmace_technicaldot_4043202.png", "date": "2026-06-10 08:01:28", "description": "Lincoln Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators that have upgraded its outlook from a previous sell rating to a hold. With a current market price of ₹637.35, the micro-cap pharmaceutical stock is showing signs of renewed strength, outperforming the broader Sensex over multiple time horizons." }, { "title": "Lincoln Pharmaceuticals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-is-rated-hold-4030683", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LincolnPharmace_mojoScore_4030683.png", "date": "2026-06-02 10:10:03", "description": "Lincoln Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 June 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Lincoln Pharmaceuticals Ltd: Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-valuation-shifts-signal-renewed-price-attractiveness-4029101", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LincolnPharmace_valuationdot_4029101.png", "date": "2026-06-02 08:01:08", "description": "Lincoln Pharmaceuticals Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating, driven by improved price-to-earnings and price-to-book ratios relative to its historical averages and peer group. Despite a recent dip in share price, the company’s fundamentals and relative valuation metrics suggest a more compelling investment case within the Pharmaceuticals & Biotechnology sector." }, { "title": "Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Market Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-technical-momentum-shifts-amid-market-volatility-4025002", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LincolnPharmace_technicaldot_4025002.png", "date": "2026-06-01 08:00:52", "description": "Lincoln Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish trend as of early June 2026. Despite a significant day decline of 16.67%, the stock’s longer-term technical indicators present a complex picture, with bullish signals on weekly and monthly MACD and OBV, contrasted by bearish monthly RSI and KST readings. This nuanced technical landscape warrants a detailed analysis for investors seeking clarity on the stock’s near-term trajectory within the Pharmaceuticals & Biotechnology sector." } ], "total": 992, "sid": "294056", "stock_news_url": "https://www.marketsmojo.com/news/lincoln-pharmaceuticals-294056" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "29-May-2026", "details": "We enclosed herewith the copies of published newspaper advertisement with respect to Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Year ended March 31 2026.", "source": "BSE" }, { "caption": "Audited Financial Results For The Quarter And Year Ended 31St March 2026", "datetime": "28-May-2026", "details": "Audited Financial Results for the Quarter and Year ended March 31 2026.", "source": "BSE" }, { "caption": "Corporate Action-Board approves Dividend", "datetime": "28-May-2026", "details": "Recommended a Final Dividend of Rs. 1.80/- (i.e 18%) per equity share of face value Rs. 10/- each for the financial year ended March 31 2026 subject to approval of the members at the ensuing Annual General Meeting of the Company.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Lincoln Pharmaceuticals Ltd has declared <strong>18%</strong> dividend, ex-date: 12 Sep 25", "dt": "2025-09-12", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Lincoln Pharmaceuticals Ltd has announced <strong>10:2</strong> stock split, ex-date: 19 Mar 09", "dt": "2009-03-19", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

1 Jun: Technical momentum shifts amid market volatility

2 Jun: Valuation upgrade to attractive signals renewed price appeal

4 Jun: Strong rebound with 5.05% gain

5 Jun: Week closes at Rs.625.05 (-1.08%)

Read full news article

Lincoln Pharmaceuticals Ltd is Rated Hold

2026-06-13 10:10:05

Lincoln Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 16 March 2026. While this rating change occurred in March, the analysis and financial metrics presented here reflect the stock's current position as of 13 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-06-11 08:01:19

Lincoln Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish trend as of mid-2026. While key indicators such as the MACD and Bollinger Bands maintain positive signals on weekly and monthly timeframes, divergences in RSI and KST readings suggest a complex outlook for investors navigating this micro-cap pharmaceutical stock.

Read full news article

Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-06-10 08:01:28

Lincoln Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators that have upgraded its outlook from a previous sell rating to a hold. With a current market price of ₹637.35, the micro-cap pharmaceutical stock is showing signs of renewed strength, outperforming the broader Sensex over multiple time horizons.

Read full news article

Lincoln Pharmaceuticals Ltd is Rated Hold

2026-06-02 10:10:03

Lincoln Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 June 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Lincoln Pharmaceuticals Ltd: Valuation Shifts Signal Renewed Price Attractiveness

2026-06-02 08:01:08

Lincoln Pharmaceuticals Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating, driven by improved price-to-earnings and price-to-book ratios relative to its historical averages and peer group. Despite a recent dip in share price, the company’s fundamentals and relative valuation metrics suggest a more compelling investment case within the Pharmaceuticals & Biotechnology sector.

Read full news article

Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Market Volatility

2026-06-01 08:00:52

Lincoln Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish trend as of early June 2026. Despite a significant day decline of 16.67%, the stock’s longer-term technical indicators present a complex picture, with bullish signals on weekly and monthly MACD and OBV, contrasted by bearish monthly RSI and KST readings. This nuanced technical landscape warrants a detailed analysis for investors seeking clarity on the stock’s near-term trajectory within the Pharmaceuticals & Biotechnology sector.

Read full news article